SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPearson Regulatory News (PSON)

Share Price Information for Pearson (PSON)

Share Price is delayed by 15 minutes
Get Live Data
1,147.00    10.50 (0.92%)
Bid:
1,144.00
Ask:
1,145.00
Spread: 1.00 (0.087%)
Market Cap: £6.89b
PSON Live PriceLast checked at - London Stock Exchange

Intraday Pearson Share Chart

Pearson: Generative AI Strategy Update

9 May 2023 09:00

RNS Number : 6746Y
Pearson PLC
09 May 2023
 

Pearson: Generative AI Strategy Update

 

London - 9th May 2023 - Pearson today updates on the generative AI enhancements in products across its portfolio. These enhancements, when combined with Pearson's unparalleled collection of high quality proprietary intellectual property assets, further strengthen the Company's position as a digital-first learning company focused on delivering an unmatched experience for the consumer across their lifetime of learning.

 

 Andy Bird, Pearson's Chief Executive, said:

"AI has played an important role across our product portfolio for many years. As generative AI develops, we expect it to create significant positive opportunities for Pearson, due to our unrivalled depth of content and data. Learners and educators place enormous trust in us so we have a responsibility to be thoughtful and considered in how we use this technology, whilst continuing to move at pace to enhance our products."

 

Pearson has adopted an AI strategy that will embed this technology across key products throughout the portfolio in a way that enhances the teaching and learning experience. With several projects well underway, Pearson is actively focused on the significant opportunities across the company, especially those using its trusted, proprietary, learning content. The company has been working to embed generative AI across a number of key products: 

 

Workforce Skills uses large language models to develop proprietary predictive algorithms which assess trends in demand for skills and occupations globally, and recommend career and learning pathways for consumers, enterprises and governments. 

 

In Mastering and MyLab, generative AI tools specifically designed to support higher education faculty are under development for Fall Back-to-School. Additional student features are under development that use Pearson proprietary content to answer questions and guide users through their problem areas. These personalised features will operate in a secure environment, so users can trust that their question attempts are not shared, and data stays free from the noise and corruption of web based AI models. 

 

In Pearson+, users will have access to a generative AI tool that automatically summarises the content of Channels videos in simple bullet points and auto generates quizzes and practice problems in the specific areas where they need more help and practice. The addition of these features is part of the ongoing strategy to build a broader base of Pearson+ users beyond higher education.

 

In English Language Learning, Pearson has developed AI based open response assessments. These give real time feedback on how to improve in writing and speaking based on the proprietary Global Scale of English. Additionally, a conversation AI tutor is in development to help with anytime, anywhere speaking practice. 

 

Pearson has a unique range of assets, supporting a diverse business model, with expertise in assessments and qualifications, language learning, workforce skills, virtual learning and higher education. Businesses outside of higher education represent the majority of profits (80%).

 

On 28th April we reported a strong Q1 performance, with underlying sales growing 6%, underpinned by each division growing in line with or ahead of our expectations. Pearson+ continues to show strong performance of paid subscriptions this Spring semester, growing threefold versus Spring 2022. We remain on track to achieve our 2023 guidance and are confident in our ability to meet our financial expectations for the medium term. Our intention is to commence a buyback to repurchase £300m of shares in the second half of 2023.

 

We will hold a briefing call at 12.00pm (BST) today with CEO, Andy Bird, Tom Ap Simon, President of Higher Education and Virtual Schools, Giovanni Giovannelli, President of English Language Learning and Mike Howells, President of Workforce Skills.

 

Conference Call:

 

Participants may call the following numbers, 10 - 15 minutes before conference start.

United Kingdom: +44 (0) 207 107 0613

United States: +1 (1) 631 570 56 13

ID Number: 42653186

 

Other international numbers available here.

 

Webcast link: https://www.investis-live.com/pearson/64527598900ed614001919c9/idda

 

Contacts

Investor Relations

Jo Russell

James Caddy

Gemma Terry

Brennan Matthews

+44 (0) 7785 451 266

+44 (0) 7825 948 218

+44 (0) 7841 363 216

+1 (332) 238-8785

 

Teneo

Charles Armitstead

 +44 (0) 7703 330 269

Notes

Forward looking statements: Except for the historical information contained herein, the matters discussed in this statement include forward-looking statements. In particular, all statements that express forecasts, expectations and projections with respect to future matters, including trends in results of operations, margins, growth rates, overall market trends, the impact of interest or exchange rates, the availability of financing, anticipated cost savings and synergies and the execution of Pearson's strategy, are forward-looking statements. By their nature, forward-looking statements involve risks and uncertainties because they relate to events and depend on circumstances that will occur in future. They are based on numerous assumptions regarding Pearson's present and future business strategies and the environment in which it will operate in the future. There are a number of factors which could cause actual results and developments to differ materially from those expressed or implied by these forward-looking statements, including a number of factors outside Pearson's control. These include international, national and local conditions, as well as competition. They also include other risks detailed from time to time in Pearson's publicly-filed documents and you are advised to read, in particular, the risk factors set out in Pearson's latest annual report and accounts, which can be found on its website (www.pearsonplc.com). Any forward-looking statements speak only as of the date they are made, and Pearson gives no undertaking to update forward-looking statements to reflect any changes in its expectations with regard thereto or any changes to events, conditions or circumstances on which any such statement is based. Readers are cautioned not to place undue reliance on such forward-looking statements.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDEAESPELDDEAA
Date   Source Headline
8th Aug 20257:00 amRNSTransaction in Own Shares
7th Aug 20257:00 amRNSTransaction in Own Shares
6th Aug 20257:00 amRNSTransaction in Own Shares
5th Aug 20257:00 amRNSTransaction in Own Shares
4th Aug 20257:00 amRNSTransaction in Own Shares
1st Aug 202512:00 pmRNSCommittee Change
1st Aug 20259:30 amRNSTotal Voting Rights
1st Aug 20257:00 amRNSPearson 2025 Interim Results
1st Aug 20257:00 amRNSTransaction in Own Shares
31st Jul 20257:00 amRNSTransaction in Own Shares
30th Jul 20257:00 amRNSTransaction in Own Shares
29th Jul 20257:00 amRNSTransaction in Own Shares
28th Jul 20257:00 amRNSTransaction in Own Shares
25th Jul 20257:00 amRNSTransaction in Own Shares
24th Jul 20257:00 amRNSTransaction in Own Shares
23rd Jul 20254:00 pmRNSDirector/PDMR Shareholding
23rd Jul 20257:00 amRNSTransaction in Own Shares
22nd Jul 20257:00 amRNSTransaction in Own Shares
21st Jul 20257:00 amRNSTransaction in Own Shares
18th Jul 20257:00 amRNSTransaction in Own Shares
17th Jul 20257:00 amRNSTransaction in Own Shares
16th Jul 20257:00 amRNSTransaction in Own Shares
15th Jul 20257:00 amRNSTransaction in Own Shares
14th Jul 20257:00 amRNSTransaction in Own Shares
11th Jul 20257:00 amRNSTransaction in Own Shares
9th Jul 20257:00 amRNSTransaction in Own Shares
8th Jul 20257:00 amRNSTransaction in Own Shares
7th Jul 20257:00 amRNSTransaction in Own Shares
3rd Jul 20255:39 pmRNSTransaction in Own Shares
3rd Jul 20254:00 pmRNSHolding(s) in Company
1st Jul 20256:03 pmRNSTransaction in Own Shares
1st Jul 20253:45 pmRNSDirector/PDMR Shareholding
1st Jul 20259:30 amRNSTotal Voting Rights
1st Jul 20257:00 amRNSAnnouncement of share repurchase programme
30th Jun 20255:19 pmRNSTransaction in Own Shares
27th Jun 20255:29 pmRNSTransaction in Own Shares
27th Jun 20254:00 pmRNSCommittee Changes
26th Jun 20255:15 pmRNSTransaction in Own Shares
25th Jun 20255:10 pmRNSTransaction in Own Shares
24th Jun 20255:12 pmRNSTransaction in Own Shares
23rd Jun 20255:24 pmRNSTransaction in Own Shares
20th Jun 20255:37 pmRNSTransaction in Own Shares
18th Jun 20255:11 pmRNSTransaction in Own Shares
17th Jun 20255:07 pmRNSTransaction in Own Shares
16th Jun 20255:10 pmRNSTransaction in Own Shares
13th Jun 20255:22 pmRNSTransaction in Own Shares
12th Jun 20255:15 pmRNSTransaction in Own Shares
11th Jun 20255:15 pmRNSTransaction in Own Shares
10th Jun 20255:03 pmRNSTransaction in Own Shares
9th Jun 20255:04 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.